Stockscreener 앱 받기
34.37
2.55%
-0.90
Tectonic Therapeutic Inc 주식(TECX)의 최신 뉴스
Price to earnings forward of Tectonic Therapeutic, Inc. – BOATS:TECX - TradingView
Here's Why We're Not Too Worried About Tectonic Therapeutic's (NASDAQ:TECX) Cash Burn Situation - Moomoo
We're Hopeful That Tectonic Therapeutic (NASDAQ:TECX) Will Use Its Cash Wisely - Sahm
MSN Money - MSN
achievement unlocked! - Moomoo
Tectonic Therapeutic (TECX) CSO exercises options and sells 172 shares under 10b5-1 plan - Stock Titan
Form 144 TECTONIC THERAPEUTIC For: 30 June By Investing.com - Investing.com Nigeria
[144] Tectonic Therapeutic, Inc. SEC Filing - Stock Titan
Tectonic Therapeutic (TECX) Stages a 3% Rally: Key Levels to Watch for Continued MomentumEnding Diagonal - dars.gov.et
Tectonic Therapeutic Inc Actuals & Estimates (NASDAQ:TECX) - TradingView
TECX Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Tectonic Therapeutic Inc For: 23 June By Investing.com - Investing.com South Africa
Tectonic Therapeutic (TECX) CEO logs routine tax withholding on vested RSUs - Stock Titan
TECXTectonic Therapeutic Inc Short Interest - Finviz
Tectonic Therapeutic Inc (TECX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TECX Q1 2026 Earnings: Deeper-than-Expected Loss Highlights Pre-Revenue StageEarnings Cycle Report - dars.gov.et
Tectonic Therapeutic Inc (TECX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tectonic Therapeutic Inc (TECX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Tectonic Therapeutic Inc (TECX) Institutional Confidence - TradingKey
Tectonic Therapeutic Inc (TECX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Tectonic Therapeutic Inc (TECX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tectonic Therapeutic Inc (TECX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tectonic Therapeutic Inc (TECX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tectonic Therapeutic Inc (TECX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tectonic Therapeutic (TECX) CFO receives 7,500 performance stock options at $16.80 - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: Humacyte (HUMA), Tectonic Therapeutic (TECX) - The Globe and Mail
Wells Fargo Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $101 - Moomoo
Tectonic completes enrollment in TX45 pulmonary hypertension trial - Investing.com UK
Tectonic completes enrollment in TX45 pulmonary hypertension trial By Investing.com - Investing.com Australia
Tectonic Therapeutic Completes Enrollment in Key TX45 Trial - TipRanks
Tectonic Therapeutic (TECX) finishes TX45 Phase 2 APEX enrollment, sets early Q1 2027 data - Stock Titan
Director at Tectonic Therapeutic (TECX) awarded 10,200 options - Stock Titan
Director at Tectonic Therapeutic (TECX) granted 10,200 stock options - Stock Titan
Tectonic Therapeutic (TECX) director receives 10,200 stock options at $28.56 - Stock Titan
Director at Tectonic Therapeutic (TECX) receives 10,200 stock options expiring 2036 - Stock Titan
Tectonic Therapeutic (TECX) awards 20,400 stock options to director - Stock Titan
New Tectonic Therapeutic (TECX) director Jessica Chutter files initial Form 3 - Stock Titan
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients - The Manila Times
Tectonic Therapeutic (TECX) Slides 2.61% as Biotech Sector Faces PressureEquity Put Call - newsline.com
TECX: All proposals passed, with directors reelected and auditor ratified; no shareholder questions - TradingView
Tectonic Therapeutic Inc. (TECX) Advances 2.50% as Shares Test Resistance Near $30.59Continuation Pattern Picks - newsline.com
Tectonic Therapeutic (TECX) Posts 2.5% Gain as Biotech Sentiment ImprovesWyckoff Spring - newsline.com
Tectonic Therapeutic Stock Climbs as Broader Market Sinks - Bez Kabli
Tectonic Therapeutic (TECX) Surges 4.65%: Strong Momentum or Technical Resistance Ahead?Triple EMA - The Legal Advocate
Tectonic Therapeutic (TECX) Slides 1.74% as Biotech Sector Headwinds PersistWeak Sell Signals - The Legal Advocate
Tectonic Therapeutic Inc. (TECX) Slips 2.53% as Biotech Sentiment Weighs on SharesSocial Sentiment - dars.gov.et
Raymond James upgrades Tectonic Therapeutic (TECX) - MSN
TECX Upgraded by Raymond James -- Price Target Raised to $81.00 - GuruFocus
Tectonic Therapeutic (TECX) Rallies 3.76% as Biotech Momentum Builds – Key Levels to WatchTrend Following Picks - The Legal Advocate
Tectonic Therapeutic Shares Rise After Raymond James Upgrade - Moomoo
TECX Q1 2026 Earnings: Loss Widens but Pipeline Optimism Drives Stock HigherAnalyst Drop Coverage - The Legal Advocate
Raymond James upgrades Tectonic Therapeutics stock rating on pipeline potential - Investing.com Nigeria
Raymond James Upgrades Tectonic Therapeutic to Strong Buy From Outperform, Adjusts PT to $81 From $76 - marketscreener.com
2.64%
자본화:
|
볼륨(24시간):